Sao Tome and Principe Tech: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sao Tome and Principe Tech.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 21, 2026

1 hours ago

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

GlobeNewswire

2 hours ago

Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

GlobeNewswire

2 hours ago

Veeco Announces Date for First Quarter 2026 Financial Results and Conference Call

GlobeNewswire

2 hours ago

Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

2 hours ago

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

GlobeNewswire

2 hours ago

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

GlobeNewswire

2 hours ago

Zscaler Wins 2026 Google Cloud Partner of the Year Award for Security in the Application Category

GlobeNewswire

2 hours ago

BlackLine Announces Date for First Quarter 2026 Earnings Release and Conference Call

GlobeNewswire

2 hours ago

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

GlobeNewswire

2 hours ago

Oculis Publishes Invitation to the Annual General Meeting

GlobeNewswire

2 hours ago

AvePoint to Announce First Quarter 2026 Financial Results on May 7

GlobeNewswire

2 hours ago

TELA Bio to Announce First Quarter 2026 Financial Results

GlobeNewswire

2 hours ago

Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting

GlobeNewswire

2 hours ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 hours ago

Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire

2 hours ago

PharmAla Issues Q2 Financial Statements and Grants Options

GlobeNewswire

2 hours ago

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

GlobeNewswire

2 hours ago

Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States

GlobeNewswire

2 hours ago

NewHydrogen Completes Critical Pre-Pilot Plant Technical Validation

GlobeNewswire

2 hours ago

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

GlobeNewswire